The National Comprehensive Cancer Network (NCCN) recently released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Cancer guidelines (Version 1.2026), which included updates to PALB2 content. To learn more, check out the full guidelines by creating a FREE account at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_bopp.pdf
Permanent link to this article: https://inheritedcancer.net/post072825/
At the National Comprehensive Cancer Network (NCCN) 2025 Annual Conference, several experts in the field of inherited cancer discussed genes related to prostate, endometrial, and gastric cancers as well as how the NCCN Guidelines for Genetic/Familial High-Risk Assessment have been updated not only for healthcare providers, but also patients and their family members with similar …
Permanent link to this article: https://inheritedcancer.net/post071225/
The National Comprehensive Cancer Network (NCCN) just released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Cancer guidelines (Version 1.2026) today! There are many updates found in these new guidelines including updates to CHEK2, PALB2, TP53, and PTEN content as well as BRCA cancer risk management and much more. To learn more, check out …
Permanent link to this article: https://inheritedcancer.net/post071025/
The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Cancer guidelines on September 11th, 2024. In these updates, NCCN clarified that it is appropriate to test unaffected (not best testable) family members when they meet testing criteria. To read more, you can check out the full guidelines by creating …
Permanent link to this article: https://inheritedcancer.net/100424_1/
The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Cancer guidelines on September 11th, 2024. In these updated guidelines, the minimal components that should be discussed during point-of-care testing are outlined (found in EVAL-A 10 of 11; Page 17). To read more, you can check out the full guidelines …
Permanent link to this article: https://inheritedcancer.net/post100324/
The National Comprehensive Cancer Network (NCCN) released updated Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Cancer guidelines on September 11th, 2024. Some updates include ⤸ To read more, you can check out the full guidelines by creating a FREE account at:https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf
Permanent link to this article: https://inheritedcancer.net/post91224/
